| |
| ADVISORY BOARD |
| |
Salima Hacein-Bey-Abina, PharmD, PhD, is director of the laboratory of gene therapy at Necker Hospital-Paris. She is one of the leaders for the first gene therapy success in the SCID-X1 disease.
Yves Beuzard, M.D., PhD, is the head of the department of Biochemistry and the laboratory of gene therapy at Saint-Louis Hospital-Paris.
Frédéric Allemand, M.D. held senior positions as director of marketing operations and outlicensing for Bayer Pharma, and as director for business development at Biovector therapeutics and Hybrigenics. He is the former head of Genopole Entreprise (in the Genopole Bioincubator at Evry, France).
|
 |
|
|
